Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
44
-
Total 13F shares, excl. options
-
12.4M
-
Shares change
-
-1.94M
-
Total reported value, excl. options
-
$143M
-
Value change
-
-$24.8M
-
Number of buys
-
15
-
Number of sells
-
-27
-
Price
-
$11.64
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q3 2020
53 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q3 2020.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.4M shares
of 23.6M outstanding shares and own 52.45% of the company stock.
Largest 10 shareholders include Capital World Investors (2.96M shares), Polygon Management Ltd. (2.15M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.57M shares), Capital International Investors (1.22M shares), Alphabet Inc. (698K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (594K shares), FRANKLIN RESOURCES INC (570K shares), BAKER BROS. ADVISORS LP (461K shares), Cormorant Asset Management, LP (422K shares), and BlackRock Inc. (326K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.